Description
| Method: | CMIA |
| Comment: | |
| Price: | 600.00 |
| Report: | Daily |
| Usage: | This assay is used for monitoring patients with a history of Prostate cancer and as an early indicator of recurrence and response to treatment. The test is commonly used for Prostate cancer screening. |
| Doctor Specialty: | Oncologist |
| Disease: | Prostate Cancer |
| Components: | |
| Courier Charges: | 0.00 |
| Home Collection: | Available |
| Department: | |
| Pre Test Information: | Do not give sample within 7 days of Digital Rectal Examination (DRE) or Rectal Prostatic Ultrasonography. |